Chemokine regulation of the inflammatory response to a low-dose influenza infection in CCR2-/- mice

Journal of Leukocyte Biology

Volumn 81, Issue 3, 2007, Pages 793-801

  Wareing, Mark D ^a,b   Lyon, Ashley ^a   Inglis, Chandra ^a   Giannoni, Francesca ^a   Charo, Israel ^a,c   Sarawar, Sally R ^a  

^a TORREY PINES INSTITUTE FOR MOLECULAR STUDIES   (United States)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cell trafficking; Lung; Neutrophils; Virus

Indexed keywords

CD40 ANTIGEN; CHEMOKINE; CHEMOKINE RECEPTOR CCR2; EOTAXIN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERFERON; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CORONAVIRUS; CYTOKINE RELEASE; DENDRITIC CELL; FLUORESCENCE ACTIVATED CELL SORTING; IMMUNE RESPONSE; INFLAMMATION; INFLUENZA; LUNG INFECTION; MACROPHAGE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS INFECTION;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELL MOVEMENT; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; FEMALE; INFLAMMATION; INFLUENZA A VIRUS; MACROPHAGES; MICE; MICE, INBRED C57BL; MONOCYTES; NEUTROPHILS; ORTHOMYXOVIRIDAE INFECTIONS; RECEPTORS, CCR2; RNA, MESSENGER;

INFLUENZA A VIRUS; MUS; ORTHOMYXOVIRIDAE;

EID: 33847781424     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0506299     Document Type: Article

References (45)

1. Stein-Streilein, J., Guffee, J. (1986) In vivo treatment of mice and hamsters with antibodies to asialo GM1 increases morbidity and mortality to pulmonary influenza infection. J. Immunol. 136, 1435-1441.
2. Tsuru, S., Fujisawa, H., Taniguchi, M., Zinnaka, Y., Nomoto, K. (1987) Mechanism of protection during the early phase of a generalized viral infection. II. Contribution of polymorphonuclear leukocytes to protection against intravenous infection with influenza virus. J. Gen. Virol. 68, 419-424.
3. Dawson, T. C., Beck, M. A., Kuziel, W. A., Henderson, F., Maeda, N. (2000) Contrasting effects of CCR5 and CCR2 deficiency in the pulmonary inflammatory response to influenza A virus. Am. J. Pathol. 156, 1951-1959.
4. Bot, A., Reichlin, A., Isobe, H., Bot, S., Schulman, J., Yokoyama, W. M., Bona, C. A. (1996) Cellular mechanisms involved in protection and recovery from influenza virus infection in immunodeficient mice. J. Virol. 70, 5668-5672.
5. Bender, B. S., Small Jr., P. A. (1992) Influenza: pathogenesis and host defense. Semin. Respir. Infect. 7, 38-45.
6. Xu, L., Yoon, H., Zhao, M. Q., Liu, J., Ramana, C. V., Enelow, R. I. (2004) Cutting edge: pulmonary immunopathology mediated by antigen-specific expression of TNF-α by antiviral CD8+ T cells. J. Immunol. 173, 721-725.
7. Hussell, T., Pennycook, A., Openshaw, P. J. (2001) Inhibition of tumor necrosis factor reduces the severity of virus-specific lung immunopathology. Eur. J. Immunol. 31, 2566-2573.
8. Christen, U., McGavern, D. B., Luster, A. D., von Herrath, M. G., Oldstone, M. B. (2003) Among CXCR3 chemokines, IFN-γ-inducible protein of 10 kDa (CXC chemokine ligand (CXCL) 10) but not monokine induced by IFN-γ (CXCL9) imprints a pattern for the subsequent development of autoimmune disease. J. Immunol. 171, 6838-6845.
9. Cerwenka, A., Morgan, T. M., Harmsen, A. G., Dutton, R. W. (1999) Migration kinetics and final destination of type 1 and type 2 CD8 effector cells predict protection against pulmonary virus infection. J. Exp. Med. 189, 423-434.
10. Wareing, M. D., Lyon, A. B., Lu, B., Gerard, C., Sarawar, S. R. (2004) Chemokine expression during the development and resolution of a pulmonary leukocyte response to influenza A virus infection in mice. J. Leukoc. Biol. 76, 886-895.
11. Cook, D. N., Beck, M. A., Coffman, T. M., Kirby, S. L., Sheridan, J. F., Pragnell, I. B., Smithies, O. (1995) Requirement of MIP-1 α for an inflammatory response to viral infection. Science 269, 1583-1585.
12. Jones, E., Price, D. A., Dahm-Vicker, M., Cerundolo, V., Klenerman, P., Gallimore, A. (2003) The influence of macrophage inflammatory protein-1α on protective immunity mediated by antiviral cytotoxic T cells. Immunology 109, 68-75.
13. Mack, M., Cihak, J., Simonis, C., Luckow, B., Proudfoot, A. E., Plachy, J., Bruhl, H., Frink, M., Anders, H. J., Vielhauer, V., Pfirstinger, J., Stangassinger, M., Schlondorff, D. (2001) Expression and characterization of the chemokine receptors CCR2 and CCR5 in mice. J. Immunol. 166, 4697-4704.
14. Sato, N., Ahuja, S. K., Quinones, M., Kostecki, V., Reddick, R. L., Melby, P. C., Kuziel, W. A., Ahuja, S. S. (2000) CC chemokine receptor (CCR)2 is required for Langerhans cell migration and localization of T helper cell type 1 (Th1)-inducing dendritic cells. Absence of CCR2 shifts the Leishmania major-resistant phenotype to a susceptible state dominated by Th2 cytokines, B cell outgrowth, and sustained neutrophilic inflammation. J. Exp. Med. 192, 205-218.
15. Nansen, A., Marker, O., Bartholdy, C., Thomsen, A. R. (2000) CCR2+ and CCR5+ CD8+ T cells increase during viral infection and migrate to sites of infection. Eur. J. Immunol. 30, 1797-1806.
16. Schecter, A. D., Berman, A. B., Yi, L., Ma, H., Daly, C. M., Soejima, K., Rollins, B. J., Charo, I. F., Taubman, M. B. (2004) MCP-1-dependent signaling in CCR2(-/-) aortic smooth muscle cells. J. Leukoc. Biol. 75, 1079-1085.
17. Blease, K., Lukacs, N. W., Hogaboam, C. M., Kunkel, S. L. (2000) Chemokines and their role in airway hyper-reactivity. Respir. Res. 1, 54-61.
18. Traynor, T. R., Herring, A. C., Dorf, M. E., Kuziel, W. A., Toews, G. B., Huffnagle, G. B. (2002) Differential roles of CC chemokine ligand 2/monocyte chemotactic protein-1 and CCR2 in the development of T1 immunity. J. Immunol. 168, 4659-4666.
19. Scott, H. M., Flynn, J. L. (2002) Mycobacterium tuberculosis in chemokine receptor 2-deficient mice: influence of dose on disease progression. Infect. Immun. 70, 5946-5954.
20. Chen, B. P., Kuziel, W. A., Lane, T. E. (2001) Lack of CCR2 results in increased mortality and impaired leukocyte activation and trafficking following infection of the central nervous system with a neurotropic coronavirus. J. Immunol. 167, 4585-4592.
21. De Lema, G. P., Maier, H., Franz, T. J., Escribese, M., Chilla, S., Segerer, S., Camarasa, N., Schmid, H., Banas, B., Kalaydjiev, S., Busch, D. H., Pfeffer, K., Mampaso, F., Schlondorff, D., Luckow, B. (2005) Chemokine receptor Ccr2 deficiency reduces renal disease and prolongs survival in MRL/lpr lupus-prone mice. J. Am. Soc. Nephrol. 16, 3592-3601.
22. Moore, B. B., Paine III, R., Christensen, P. J., Moore, T. A., Sitterding, S., Ngan, R., Wilke, C. A., Kuziel, W. A., Toews, G. B. (2001) Protection from pulmonary fibrosis in the absence of CCR2 signaling. J. Immunol. 167, 4368-4377.
23. Moore, B. B., Kolodsick, J. E., Thannickal, V. J., Cooke, K., Moore, T. A., Hogaboam, C., Wilke, C. A., Toews, G. B. (2005) CCR2-mediated recruitment of fibrocytes to the alveolar space after fibrotic injury. Am. J. Pathol. 166, 675-684.
24. Boring, L., Gosling, J., Cleary, M., Charo, I. F. (1998) Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 394, 894-897.
25. Hokeness, K. L., Kuziel, W. A., Biron, C. A., Salazar-Mather, T. P. (2005) Monocyte chemoattractant protein-1 and CCR2 interactions are required for IFN-α/β-induced inflammatory responses and antiviral defense in liver. J. Immunol. 174, 1549-1556.
26. Peters, W., Scott, H. M., Chambers, H. F., Flynn, J. L., Charo, I. F., Ernst, J. D. (2001) Chemokine receptor 2 serves an early and essential role in resistance to Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 98, 7958-7963.
27. Boring, L., Gosling, J., Chensue, S. W., Kunkel, S. L., Farese Jr., R. V., Broxmeyer, H. E., Charo, I. F. (1997) Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice. J. Clin. Invest. 100, 2552-2561.
28. Tannock, G. A., Paul, J. A., Barry, R. D. (1984) Relative immunogenicity of the cold-adapted influenza virus A/Ann Arbor/6/60 (A/AA/6/60-ca), recombinants of A/AA/6/60-ca, and parental strains with similar surface antigens. Infect. Immun. 43, 457-462.
29. Sarawar, S. R., Lee, B. J., Anderson, M., Teng, Y. C., Zuberi, R., Von Gesjen, S. (2002) Chemokine induction and leukocyte trafficking to the lungs during murine herpesvirus 68 (MHV-68) infection. Virology 293, 54-62.
30. Bischoff, D. S., Zhu, J. H., Makhijani, N. S., Yamaguchi, D. T. (2005) KC chemokine expression by TGF-β in C3H10T1/2 cells induced towards osteoblasts. Biochem. Biophys. Res. Commun. 326, 364-370.
31. Biswas, R., Datta, S., Gupta, J. D., Novotny, M., Tebo, J., Hamilton, T. A. (2003) Regulation of chemokine mRNA stability by lipopolysaccharide and IL-10. J. Immunol. 170, 6202-6208.
32. Peters, W., Cyster, J. G., Mack, M., Schlondorff, D., Wolf, A. J., Ernst, J. D., Charo, I. F. (2004) CCR2-dependent trafficking of F4/80dim macrophages and CD11cdim/intermediate dendritic cells is crucial for T cell recruitment to lungs infected with Mycobacterium tuberculosis. J. Immunol. 172, 7647-7653.
33. Cadillac, J. M., Sigler, R. E., Weinberg, J. B., Lutzke, M. L., Rochford, R. (2005) Herpesvirus-induced lung pathology is altered in the absence of macrophages. Lung 183, 239-251.
34. Sakai, S., Kawamata, H., Mantani, N., Kogure, T., Shimada, Y., Terasawa, K., Sakai, T., Imanishi, N., Ochiai, H. (2000) Therapeutic effect of anti-macrophage inflammatory protein 2 antibody on influenza virus-induced pneumonia in mice. J. Virol. 74, 2472-2476.
35. Oliveira, S. H., Lira, S., Martinez, A. C., Wiekowski, M., Sullivan, L., Lukacs, N. W. (2002) Increased responsiveness of murine eosinophils to MIP-1β (CCL4) and TCA-3 (CCL1) is mediated by their specific receptors, CCR5 and CCR8. J. Leukoc. Biol. 71, 1019-1025.
36. Lukacs, N. W., Standiford, T. J., Chensue, S. W., Kunkel, R. G., Strieter, R. M., Kunkel, S. L. (1996) C-C chemokine-induced eosinophil chemotaxis during allergic airway inflammation. J. Leukoc. Biol. 60, 573-578.
37. Goser, S., Andrassy, M., Buss, S. J., Leuschner, F., Volz, C. H., Ottl, R., Zittrich, S., Blaudeck, N., Hardt, S. E., Pfitzer, G., Rose, N. R., Katus, H. A., Kaya, Z. (2006) Cardiac troponin I but not cardiac troponin T induces severe autoimmune inflammation in the myocardium. Circulation 114, 1693-1702.
38. Zheng, L., He, M., Long, M., Blomgran, R., Stendahl, O. (2004) Pathogen-induced apoptotic neutrophils express heat shock proteins and elicit activation of human macrophages. J. Immunol. 173, 6319-6326.
39. Thomassen, M. J., Divis, L. T., Fisher, C. J. (1996) Regulation of human alveolar macrophage inflammatory cytokine production by interleukin-10. Clin. Immunol. Immunopathol. 80, 321-324.
40. Robben, P. M., Laregina, M., Kuziel, W. A., Sibley, L. D. (2005) Recruitment of Gr-1+ monocytes is essential for control of acute toxoplasmosis. J. Exp. Med. 201, 1761-1769.
41. Grattendick, K., Stuart, R., Roberts, E., Lincoln, J., Lefkowitz, S. S., Bollen, A., Moguilevsky, N., Friedman, H., Lefkowitz, D. L. (2002) Alveolar macrophage activation by myeloperoxidase: a model for exacerbation of lung inflammation. Am. J. Respir. Cell Mol. Biol. 26, 716-722.
42. Speyer, C. L., Gao, H., Rancilio, N. J., Neff, T. A., Huffnagle, G. B., Sarma, J. V., Ward, P. A. (2004) Novel chemokine responsiveness and mobilization of neutrophils during sepsis. Am. J. Pathol. 165, 2187-2196.
43. Traynor, T. R., Kuziel, W. A., Toews, G. B., Huffnagle, G. B. (2000) CCR2 expression determines T1 versus T2 polarization during pulmonary Cryptococcus neoformans infection. J. Immunol. 164, 2021-2027.
44. Chiu, B. C., Freeman, C. M., Stolberg, V. R., Hu, J. S., Zeibecoglou, K., Lu, B., Gerard, C., Charo, I. F., Lira, S. A., Chensue, S. W. (2004) Impaired lung dendritic cell activation in CCR2 knockout mice. Am. J. Pathol. 165, 1199-1209.
45. Graham, M. B., Braciale, T. J. (1997) Resistance to and recovery from lethal influenza virus infection in B lymphocyte-deficient mice. J. Exp. Med. 186, 2063-2068.